R-Pag Tablet 50 mg contains Eltrombopag Olamine, a thrombopoietin receptor agonist specifically formulated to treat patients with low platelet counts (thrombocytopenia). Eltrombopag stimulates platelet production by acting on megakaryocytes in the bone marrow, supporting safer platelet levels and reducing the risk of bleeding.

R-Pag Tablet 50 mg is prescribed for adult patients with conditions such as chronic immune thrombocytopenia (ITP), thrombocytopenia associated with chronic liver disease, or chemotherapy-induced thrombocytopenia. The higher-dose tablet provides robust platelet support for patients requiring a stronger effect under careful medical supervision. Its oral formulation ensures convenient administration and reliable absorption.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

R-Pag Tablet 50 mg is indicated for:

• Chronic Immune Thrombocytopenia (ITP): For patients who have not responded adequately to conventional therapies such as corticosteroids or immunoglobulins.

• Thrombocytopenia due to chronic liver disease: To increase platelet counts prior to elective procedures.

• Chemotherapy-induced thrombocytopenia: To aid platelet recovery in patients undergoing myelosuppressive cancer therapy.

This dose is particularly suitable for patients requiring significant platelet elevation with regular monitoring by a healthcare professional.

Dosage and Administration

• The recommended starting dose is 50 mg once daily, taken orally at least 2 hours before or 4 hours after meals containing calcium, to ensure optimal absorption.

• Swallow tablets whole with water; do not crush or chew.

• Dose adjustments are based on platelet count response and patient condition, monitored regularly by a physician.

• Continue therapy until platelet counts stabilize or as advised; do not discontinue abruptly without medical guidance.

Mechanism of Action

Eltrombopag Olamine in R-Pag Tablet works by:

• Stimulating thrombopoietin receptors on bone marrow megakaryocytes

• Enhancing platelet production and maturation

• Supporting maintenance of safe platelet counts, thereby reducing the risk of bleeding

This mechanism mimics natural thrombopoietin activity, providing targeted support for patients with thrombocytopenia.

Precautions

• Use only under medical supervision.

• Monitor platelet counts and liver function regularly to avoid excessive platelet production or hepatic complications.

• Inform the physician of allergies, liver disease, or concurrent medications.

• Avoid combining with other drugs affecting platelet function unless prescribed.

• Pregnancy and breastfeeding should only be considered under physician guidance.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

R-Pag Tablet 50 mg is generally well-tolerated. Possible side effects include:

• Headache, fatigue, or dizziness

• Mild gastrointestinal discomfort such as nausea

• Rarely, liver function abnormalities or thromboembolic events

• Most side effects can be managed with dose adjustment and close monitoring

Storage

Store R-Pag Tablet 50 mg in a cool, dry place below 25°C, away from light and moisture. Keep out of reach of children.

R-Pag Tablet 50 mg is a powerful and effective oral therapy for thrombocytopenia, helping adult patients maintain safe platelet levels, reduce bleeding risk, and improve quality of life under proper medical supervision.